Accessibility Statement
Our Strategy

Our Sustainability Strategy and Governance

Our sustainability strategy and efforts directly support Lilly’s purpose to discover and develop medicines that make life better. We are striving to: 

  • Expand equitable access to medicines for more people around the world 

  • Improve health care for people living in areas with limited resources 

  • Strengthen communities and address social issues that matter to our business, employees and society 

  • Empower a diverse workforce, harnessing a variety of perspectives to discover and deliver medicines 

  • Reduce our environmental impact across the life cycles of our products and our supply chains 

  • Operate ethically and responsibly, guided by our core values of integrity, excellence and respect for people. 

Our sustainability goals are integrated into our business strategy and operations. We set ambitious, measurable goals and report on our progress through this site and other communications with stakeholders. 

Our Board is actively engaged in the identification and oversight of strategic sustainability matters at Lilly. Our CEO and Executive Committee are responsible for management of our sustainability goals and their contribution to achieving our sustainability commitments is embedded into their personal performance evaluations. In addition, we actively engage our global employees in our sustainability efforts where they may have individual and collective impact. 

Lilly’s Sustainability Priorities

Social: Governance:
Social: Governance:
Social: Governance:
Social: Governance:
Social: Governance:
Social: Governance:
Social: Governance:

Stakeholder Engagement and Topic Identification

Lilly solicits input from internal and external people and organizations to better determine the sustainability issues that matter most to our company and stakeholders. We obtain input and prioritization from:

In addition to engaging with stakeholders, we frequently conduct peer benchmarking and integrate industry and sustainability trends. We also leverage relevant sustainability reporting frameworks, including the Sustainability Accounting Standards Board (SASB) and Task Force on Climate-related Financial Disclosures (TCFD). 

Through this process, we focus on the 15 sustainability topics noted above, which represent important issues to internal and external stakeholders and are key to our company’s long-term success. These topics are aligned with the SASB standards for the Biotechnology and Pharmaceutical industry, as well as environmental issues addressed by TCFD. Our sustainability strategy is dynamic, and we review these priorities periodically to align our approach with topics that are relevant for Lilly, our stakeholders and our industry. 

See important information about our Sustainability report.